chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Gait inability, Insomnia, Mobility decreased, Muscle tightness
Clinical narrative: Arm hurts; Still has some tightness when he bends it in; Not being able to move his leg/could not straighten it/could not bend it; kept on waking up/ not sleeping last night; Throbbing; Left knee started hurting so bad/agonizing pain, agonizing joint pain in his left knee he describes it as a banging pain in the knee for multiple hours; He could not walk; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts), GAIT INABILITY (He could not walk), MUSCLE TIGHTNESS (Still has some tightness when he bends it in), MOBILITY DECREASED (Not being able to move his leg/could not straighten it/could not bend it) and INSOMNIA (kept on waking up/ not sleeping last night) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Aug-2021, the patient experienced GAIT INABILITY (He could not walk), MOBILITY DECREASED (Not being able to move his leg/could not straighten it/could not bend it), INSOMNIA (kept on waking up/ not sleeping last night), PAIN (Throbbing) and ARTHRALGIA (Left knee started hurting so bad/agonizing pain, agonizing joint pain in his left knee he describes it as a banging pain in the knee for multiple hours). On 09-Aug-2021, the patient experienced MUSCLE TIGHTNESS (Still has some tightness when he bends it in). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurts). On 09-Aug-2021, GAIT INABILITY (He could not walk), MOBILITY DECREASED (Not being able to move his leg/could not straighten it/could not bend it), INSOMNIA (kept on waking up/ not sleeping last night), PAIN (Throbbing) and ARTHRALGIA (Left knee started hurting so bad/agonizing pain, agonizing joint pain in his left knee he describes it as a banging pain in the knee for multiple hours) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm hurts) and MUSCLE TIGHTNESS (Still has some tightness when he bends it in) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Reporter Information and event added. On 09-Aug-2021: Event details added
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Arm hurts; Still has some tightness when he bends it in; Not being able to move his leg/could not straighten it/could not bend it; kept on waking up/ not sleeping last night; Throbbing; Left knee started hurting so bad/agonizing pain, agonizing joint pain in his left knee he describes it as a banging pain in the knee for multiple hours; He could not walk; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts), GAIT INABILITY (He could not walk), MUSCLE TIGHTNESS (Still has some tightness when he bends it in), MOBILITY DECREASED (Not being able to move his leg/could not straighten it/could not bend it) and INSOMNIA (kept on waking up/ not sleeping last night) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Aug-2021, the patient experienced GAIT INABILITY (He could not walk), MOBILITY DECREASED (Not being able to move his leg/could not straighten it/could not bend it), INSOMNIA (kept on waking up/ not sleeping last night), PAIN (Throbbing) and ARTHRALGIA (Left knee started hurting so bad/agonizing pain, agonizing joint pain in his left knee he describes it as a banging pain in the knee for multiple hours). On 09-Aug-2021, the patient experienced MUSCLE TIGHTNESS (Still has some tightness when he bends it in). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurts). On 09-Aug-2021, GAIT INABILITY (He could not walk), MOBILITY DECREASED (Not being able to move his leg/could not straighten it/could not bend it), INSOMNIA (kept on waking up/ not sleeping last night), PAIN (Throbbing) and ARTHRALGIA (Left knee started hurting so bad/agonizing pain, agonizing joint pain in his left knee he describes it as a banging pain in the knee for multiple hours) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm hurts) and MUSCLE TIGHTNESS (Still has some tightness when he bends it in) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Reporter Information and event added. On 09-Aug-2021: Event details added
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Peripheral swelling
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of burning sensation on toes and peripheral swelling (right leg swelling after receiving the Moderna first shot) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19  immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced burning sensation on toes and peripheral swelling (right leg swelling after receiving the Moderna first shot). At the time of the report, burning sensation on toes and peripheral swelling (right leg swelling after receiving the Moderna first shot): not resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: Side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (Side effects). At the time of the report, ADVERSE REACTION (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Diagnosed with COVID about two weeks later after shot; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with COVID about two weeks later after shot) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced COVID-19 (Diagnosed with COVID about two weeks later after shot). The patient was treated with Immunotherapy (monoclonal infusion on 23-Mar-2021) for COVID-19. At the time of the report, COVID-19 (Diagnosed with COVID about two weeks later after shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Mar-2021, SARS-CoV-2 test: positive (Positive) Diagnosed with COVID about two weeks later after shot..         No concomitant medications were reported  Treatment included Monoclonal infusion on 23-March-2021.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dizziness
Clinical narrative: Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical history was provided by reporter.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for Blood pressure high.    On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Aug-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided by reporter.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: he has not  recieved his 2nd dose.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (he has not  recieved his 2nd dose.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (he has not  recieved his 2nd dose.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (he has not  recieved his 2nd dose.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported by the Reporter. The treatment information was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (right side is hurting instead of left where the shot was injected) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Aug-2021, the patient experienced PAIN IN EXTREMITY (right side is hurting instead of left where the shot was injected). At the time of the report, PAIN IN EXTREMITY (right side is hurting instead of left where the shot was injected) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant was provided. No treatment was provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Feeling abnormal, Myalgia, Nausea
Clinical narrative: Weak; feel awful; Fever; Muscle pain; Tiredness; Nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Aug-2021 and was forwarded to Moderna on 09-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), FEELING ABNORMAL (feel awful), PYREXIA (Fever), MYALGIA (Muscle pain) and FATIGUE (Tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weak), FEELING ABNORMAL (feel awful), PYREXIA (Fever), MYALGIA (Muscle pain), FATIGUE (Tiredness) and NAUSEA (Nausea). At the time of the report, ASTHENIA (Weak), FEELING ABNORMAL (feel awful), PYREXIA (Fever), MYALGIA (Muscle pain), FATIGUE (Tiredness) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. No treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Weak; feel awful; Fever; Muscle pain; Tiredness; Nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Aug-2021 and was forwarded to Moderna on 09-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), FEELING ABNORMAL (feel awful), PYREXIA (Fever), MYALGIA (Muscle pain) and FATIGUE (Tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weak), FEELING ABNORMAL (feel awful), PYREXIA (Fever), MYALGIA (Muscle pain), FATIGUE (Tiredness) and NAUSEA (Nausea). At the time of the report, ASTHENIA (Weak), FEELING ABNORMAL (feel awful), PYREXIA (Fever), MYALGIA (Muscle pain), FATIGUE (Tiredness) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. No treatment information was reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Nodule, Pain in extremity, Pyrexia
Clinical narrative: A knot  on her  one arm; Achy arm; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NODULE (A knot  on her  one arm), PAIN IN EXTREMITY (Achy arm), PYREXIA (Fever) and HEADACHE (Headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006D21A and 045C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Aug-2021, the patient experienced NODULE (A knot  on her  one arm), PAIN IN EXTREMITY (Achy arm), PYREXIA (Fever) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, NODULE (A knot  on her  one arm), PAIN IN EXTREMITY (Achy arm), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Aug-2021, Body temperature: 106 f (High) 106 F.         Concomitant- A medication for migraine   This case was linked to MOD21-128456 (Patient Link).
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose, Glycosylated haemoglobin, Inappropriate schedule of product administration, Mobility decreased, Pain
Clinical narrative: could not lift his hand after the vaccine; pain; fever; first dose on 23 Feb 2021 and second dose 3 Mar 2021; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (could not lift his hand after the vaccine), PAIN (pain), PYREXIA (fever) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 23 Feb 2021 and second dose 3 Mar 2021) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 23 Feb 2021 and second dose 3 Mar 2021). On an unknown date, the patient experienced MOBILITY DECREASED (could not lift his hand after the vaccine), PAIN (pain) and PYREXIA (fever). On 03-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 23 Feb 2021 and second dose 3 Mar 2021) had resolved. At the time of the report, MOBILITY DECREASED (could not lift his hand after the vaccine) outcome was unknown and PAIN (pain) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: abnormal (abnormal) Blood sugar level was abnormal. On an unknown date, Glycosylated haemoglobin: increased (High) Glycosylated hemoglobin was increased. On an unknown date, Thyroid function test: 14 (abnormal) 14.         No concomitant medications was provided.  No treatment medications was provided.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Thyroid function test
Clinical narrative: could not lift his hand after the vaccine; pain; fever; first dose on 23 Feb 2021 and second dose 3 Mar 2021; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (could not lift his hand after the vaccine), PAIN (pain), PYREXIA (fever) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 23 Feb 2021 and second dose 3 Mar 2021) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 23 Feb 2021 and second dose 3 Mar 2021). On an unknown date, the patient experienced MOBILITY DECREASED (could not lift his hand after the vaccine), PAIN (pain) and PYREXIA (fever). On 03-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose on 23 Feb 2021 and second dose 3 Mar 2021) had resolved. At the time of the report, MOBILITY DECREASED (could not lift his hand after the vaccine) outcome was unknown and PAIN (pain) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: abnormal (abnormal) Blood sugar level was abnormal. On an unknown date, Glycosylated haemoglobin: increased (High) Glycosylated hemoglobin was increased. On an unknown date, Thyroid function test: 14 (abnormal) 14.         No concomitant medications was provided.  No treatment medications was provided.
Sex: F
Vaccine: COVID19
Symptoms: Immune system disorder, Nervous system disorder, Vaccination site mass, Vaccination site pruritus, Vaccination site rash
Clinical narrative: red big knot bigger than a 50 cent coin; affecting her nervous system; affecting her immune system; real itchy; red bumps on her arm (where she got the shot) and her legs; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Aug-2021 and was forwarded to Moderna on 09-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (red big knot bigger than a 50 cent coin), NERVOUS SYSTEM DISORDER (affecting her nervous system), IMMUNE SYSTEM DISORDER (affecting her immune system), VACCINATION SITE PRURITUS (real itchy) and VACCINATION SITE RASH (red bumps on her arm (where she got the shot) and her legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (red big knot bigger than a 50 cent coin), NERVOUS SYSTEM DISORDER (affecting her nervous system), IMMUNE SYSTEM DISORDER (affecting her immune system), VACCINATION SITE PRURITUS (real itchy) and VACCINATION SITE RASH (red bumps on her arm (where she got the shot) and her legs). At the time of the report, VACCINATION SITE MASS (red big knot bigger than a 50 cent coin), NERVOUS SYSTEM DISORDER (affecting her nervous system), IMMUNE SYSTEM DISORDER (affecting her immune system) and VACCINATION SITE PRURITUS (real itchy) outcome was unknown and VACCINATION SITE RASH (red bumps on her arm (where she got the shot) and her legs) had not resolved.            No concomitant medications were reported. No treatment information was reported. No other information were provided as the consumer was very upset.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis
Clinical narrative: Looks like arthritis in my thumb finger; Joint pain/Extreme knee pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (Looks like arthritis in my thumb finger) and ARTHRALGIA (Joint pain/Extreme knee pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (Looks like arthritis in my thumb finger) and ARTHRALGIA (Joint pain/Extreme knee pain). At the time of the report, ARTHRITIS (Looks like arthritis in my thumb finger) and ARTHRALGIA (Joint pain/Extreme knee pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Got 2nd dose past 42 days; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got 2nd dose past 42 days) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040C21A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got 2nd dose past 42 days). On 11-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got 2nd dose past 42 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication details not  reported. Inappropriate schedule of vaccine administered.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: first dose about 4 months ago but have waited to get my second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first dose about 4 months ago but have waited to get my second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (first dose about 4 months ago but have waited to get my second dose). On 09-Aug-2021, PRODUCT DOSE OMISSION ISSUE (first dose about 4 months ago but have waited to get my second dose) had resolved.            No concomitant medications were reported. No treatment medications were reported.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   Reporter did not allow further contact
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Product dose omission issue
Clinical narrative: It has been more than 36 days and the patient did not receive the second dose; very swollen lymph nodes from head to toe; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (It has been more than 36 days and the patient did not receive the second dose) and LYMPHADENOPATHY (very swollen lymph nodes from head to toe) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (It has been more than 36 days and the patient did not receive the second dose) and LYMPHADENOPATHY (very swollen lymph nodes from head to toe). At the time of the report, PRODUCT DOSE OMISSION ISSUE (It has been more than 36 days and the patient did not receive the second dose) had resolved and LYMPHADENOPATHY (very swollen lymph nodes from head to toe) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Vaccine 2 was delayed by 12 weeks) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Vaccine 2 was delayed by 12 weeks). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Vaccine 2 was delayed by 12 weeks) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Concomitant medications were reported. No Treatment information was reported.
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine to 16 year old; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine to 16 year old) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine to 16 year old). On 09-Aug-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine to 16 year old) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-Aug-2021: Follow up received contains no new information.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Chills, Fatigue, Joint swelling, Mobility decreased
Clinical narrative: knuckles are inflamed which is ongoing; hands are not functioning; was tired; joints of both hands are swollen; achy arm/hands began hurting/arm hurt; chills; felt like she had a fever; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (knuckles are inflamed which is ongoing), JOINT SWELLING (joints of both hands are swollen), MOBILITY DECREASED (hands are not functioning), VACCINATION SITE PAIN (achy arm/hands began hurting/arm hurt) and FATIGUE (was tired) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033B21A and 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: STEROIDS (3 weeks prior to first dose of Moderna vaccine) and PNEUMOCOCCAL VACCINE (3 weeks prior to first dose of Moderna vaccine). Concomitant products included TIZANIDINE for Back pain.   On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced JOINT SWELLING (joints of both hands are swollen). On an unknown date, the patient experienced ARTHRITIS (knuckles are inflamed which is ongoing), MOBILITY DECREASED (hands are not functioning), VACCINATION SITE PAIN (achy arm/hands began hurting/arm hurt), FATIGUE (was tired), CHILLS (chills) and PYREXIA (felt like she had a fever). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of unknown and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, ARTHRITIS (knuckles are inflamed which is ongoing) and JOINT SWELLING (joints of both hands are swollen) had not resolved and MOBILITY DECREASED (hands are not functioning), VACCINATION SITE PAIN (achy arm/hands began hurting/arm hurt), FATIGUE (was tired), CHILLS (chills) and PYREXIA (felt like she had a fever) outcome was unknown.            concomitant medication includes OTC allergy medications. patient had Lyme test which was negative since patient was bit by a tick around the same time received the 2nd dose.   This case was linked to MOD-2021-281139 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: knuckles are inflamed which is ongoing; hands are not functioning; was tired; joints of both hands are swollen; achy arm/hands began hurting/arm hurt; chills; felt like she had a fever; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (knuckles are inflamed which is ongoing), JOINT SWELLING (joints of both hands are swollen), MOBILITY DECREASED (hands are not functioning), VACCINATION SITE PAIN (achy arm/hands began hurting/arm hurt) and FATIGUE (was tired) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033B21A and 045B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: STEROIDS (3 weeks prior to first dose of Moderna vaccine) and PNEUMOCOCCAL VACCINE (3 weeks prior to first dose of Moderna vaccine). Concomitant products included TIZANIDINE for Back pain.   On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced JOINT SWELLING (joints of both hands are swollen). On an unknown date, the patient experienced ARTHRITIS (knuckles are inflamed which is ongoing), MOBILITY DECREASED (hands are not functioning), VACCINATION SITE PAIN (achy arm/hands began hurting/arm hurt), FATIGUE (was tired), CHILLS (chills) and PYREXIA (felt like she had a fever). The patient was treated with NAPROXEN SODIUM (ALEVE) at a dose of unknown and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, ARTHRITIS (knuckles are inflamed which is ongoing) and JOINT SWELLING (joints of both hands are swollen) had not resolved and MOBILITY DECREASED (hands are not functioning), VACCINATION SITE PAIN (achy arm/hands began hurting/arm hurt), FATIGUE (was tired), CHILLS (chills) and PYREXIA (felt like she had a fever) outcome was unknown.            concomitant medication includes OTC allergy medications. patient had Lyme test which was negative since patient was bit by a tick around the same time received the 2nd dose.   This case was linked to MOD-2021-281139 (Patient Link).
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash, Swelling
Clinical narrative: weird internal feeling like a big swelling, neck, face and arm have the feeling too.; internal sore in arm; Rash in left arm; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (weird internal feeling like a big swelling, neck, face and arm have the feeling too.), PAIN IN EXTREMITY (internal sore in arm) and RASH (Rash in left arm) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 31-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jul-2021, the patient experienced RASH (Rash in left arm). On 05-Aug-2021, the patient experienced SWELLING (weird internal feeling like a big swelling, neck, face and arm have the feeling too.) and PAIN IN EXTREMITY (internal sore in arm). At the time of the report, SWELLING (weird internal feeling like a big swelling, neck, face and arm have the feeling too.) had not resolved and PAIN IN EXTREMITY (internal sore in arm) and RASH (Rash in left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported. No lab data was provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: I had the first vaccine shot in early April but it's been 4 months.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I had the first vaccine shot in early April but it's been 4 months.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I had the first vaccine shot in early April but it's been 4 months.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I had the first vaccine shot in early April but it's been 4 months.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No Treatment medications were reported.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Vaccine has not been administered >36 days after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Vaccine has not been administered >36 days after 1st dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient got very sick with COVID. She was in the hospital on a ventilator for a week and almost died due to COVID. She didn't get discharged from the hospital until SEP 2020.) in July 2020. Concomitant products included SERTRALINE, LOSARTAN, BENZTROPINE [BENZATROPINE] and ATORVASTATIN for an unknown indication.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Vaccine has not been administered >36 days after 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Vaccine has not been administered >36 days after 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was supposed to receive her second dose in JUN-2021.  No treatment information was provided.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Body temperature, COVID-19, Feeling abnormal
Clinical narrative: Lost his sense of taste/ could not taste his Budweiser; Lost his sense of smell; Tested positive for COVID; temperature of 104.8/ temperature was 100.8/  temperature was 101.2; feeling bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling bad), AGEUSIA (Lost his sense of taste/ could not taste his Budweiser), ANOSMIA (Lost his sense of smell), COVID-19 (Tested positive for COVID) and PYREXIA (temperature of 104.8/ temperature was 100.8/  temperature was 101.2) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE and LISINOPRIL for an unknown indication.   On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced FEELING ABNORMAL (feeling bad). On 24-Jul-2021, the patient experienced PYREXIA (temperature of 104.8/ temperature was 100.8/  temperature was 101.2). On 26-Jul-2021, the patient experienced COVID-19 (Tested positive for COVID). On an unknown date, the patient experienced AGEUSIA (Lost his sense of taste/ could not taste his Budweiser) and ANOSMIA (Lost his sense of smell). On 04-Aug-2021, COVID-19 (Tested positive for COVID) had resolved. At the time of the report, FEELING ABNORMAL (feeling bad), AGEUSIA (Lost his sense of taste/ could not taste his Budweiser), ANOSMIA (Lost his sense of smell) and PYREXIA (temperature of 104.8/ temperature was 100.8/  temperature was 101.2) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jul-2021, Body temperature: 104.8 (High) 104.8. On 25-Jul-2021, Body temperature: 101.2 (High) 101.2. On 26-Jul-2021, Body temperature: 100.8 (High) 100.8. On 26-Jul-2021, SARS-CoV-2 test: postive (Positive) postive. On 04-Aug-2021, SARS-CoV-2 test: negative (Negative) negative.         No concomitant medications were reported by the reporter.  No Treatment information was provided by the reporter.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Lost his sense of taste/ could not taste his Budweiser; Lost his sense of smell; Tested positive for COVID; temperature of 104.8/ temperature was 100.8/  temperature was 101.2; feeling bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling bad), AGEUSIA (Lost his sense of taste/ could not taste his Budweiser), ANOSMIA (Lost his sense of smell), COVID-19 (Tested positive for COVID) and PYREXIA (temperature of 104.8/ temperature was 100.8/  temperature was 101.2) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE and LISINOPRIL for an unknown indication.   On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced FEELING ABNORMAL (feeling bad). On 24-Jul-2021, the patient experienced PYREXIA (temperature of 104.8/ temperature was 100.8/  temperature was 101.2). On 26-Jul-2021, the patient experienced COVID-19 (Tested positive for COVID). On an unknown date, the patient experienced AGEUSIA (Lost his sense of taste/ could not taste his Budweiser) and ANOSMIA (Lost his sense of smell). On 04-Aug-2021, COVID-19 (Tested positive for COVID) had resolved. At the time of the report, FEELING ABNORMAL (feeling bad), AGEUSIA (Lost his sense of taste/ could not taste his Budweiser), ANOSMIA (Lost his sense of smell) and PYREXIA (temperature of 104.8/ temperature was 100.8/  temperature was 101.2) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jul-2021, Body temperature: 104.8 (High) 104.8. On 25-Jul-2021, Body temperature: 101.2 (High) 101.2. On 26-Jul-2021, Body temperature: 100.8 (High) 100.8. On 26-Jul-2021, SARS-CoV-2 test: postive (Positive) postive. On 04-Aug-2021, SARS-CoV-2 test: negative (Negative) negative.         No concomitant medications were reported by the reporter.  No Treatment information was provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: First dose 5 months ago / can i now take the 2nd dose; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (First dose 5 months ago / can i now take the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (First dose 5 months ago / can i now take the 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (First dose 5 months ago / can i now take the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment medication were reported.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Now testing positive for COVID; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Now testing positive for COVID) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Now testing positive for COVID). At the time of the report, COVID-19 (Now testing positive for COVID) outcome was unknown. Not Provided          No Concomitant medications were reported.  No Treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Swelling in fingers; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling in fingers) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling in fingers). At the time of the report, PERIPHERAL SWELLING (Swelling in fingers) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Concomitant medications were reported. No Treatment information was reported.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Sexually transmitted disease, Treponema test
Clinical narrative: The patient had an STD (sexually transmitted disease); This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Aug-2021 and was forwarded to Moderna on 09-Aug-2021.    This spontaneous case was reported by an other health care professional and describes the occurrence of SEXUALLY TRANSMITTED DISEASE (The patient had an STD (sexually transmitted disease)) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SEXUALLY TRANSMITTED DISEASE (The patient had an STD (sexually transmitted disease)). At the time of the report, SEXUALLY TRANSMITTED DISEASE (The patient had an STD (sexually transmitted disease)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jul-2021, Treponema test: reactive (Inconclusive) Reactive, positive (Positive) Positive/False positive and reactive (Inconclusive) Reactive. On 29-Jul-2021, Treponema test: non reactive (Inconclusive) Non Reactive, reactive (Inconclusive) Reactive and reactive (Inconclusive) Reactive. On an unknown date, Treponema test: non reactive (Inconclusive) Non reactive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient did not had any history of exposure or symptoms. Concomitant and Treatment medications were not reported.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: got my first shot 4/29. is it too late now to get second?; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (got my first shot 4/29. is it too late now to get second?) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (got my first shot 4/29. is it too late now to get second?). At the time of the report, PRODUCT DOSE OMISSION ISSUE (got my first shot 4/29. is it too late now to get second?) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products were not provided by the reporter. Treatment information was not provided.